US Stock MarketDetailed Quotes

Plus Therapeutics (PSTV)

Watchlist

5.850
-0.190-3.15%

Close May 12 16:00 ET

5.900
+0.050+0.85%

Post 19:44 ET

40.14MMarket Cap-0.81P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Plus Therapeutics (PSTV) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

4.10%15.3M

47.23%5.74M

17.98%4.48M

-58.40%1.54M

7.18%3.54M

10.31%14.7M

1.09%3.9M

16.86%3.8M

148.12%3.7M

-30.14%3.3M

Selling and administrative expenses

22.06%12.13M

33.33%4.17M

43.64%3.44M

-23.65%1.68M

28.29%2.84M

16.33%9.94M

31.51%3.13M

19.97%2.4M

14.50%2.2M

-1.43%2.21M

-General and administrative expense

22.06%12.13M

33.33%4.17M

43.64%3.44M

-23.65%1.68M

28.29%2.84M

16.33%9.94M

31.51%3.13M

19.97%2.4M

14.50%2.2M

-1.43%2.21M

Research and development costs

-20.80%8.38M

34.54%2.94M

-14.77%2.44M

-55.07%1.25M

-36.45%1.76M

9.18%10.58M

-21.76%2.19M

14.64%2.86M

95.28%2.77M

-7.38%2.76M

Other operating expenses

10.49%-5.21M

3.19%-1.37M

4.05%-1.4M

-8.68%-1.39M

36.85%-1.06M

-18.54%-5.82M

-7.54%-1.41M

-17.42%-1.46M

31.01%-1.28M

-231.42%-1.68M

Operating profit

-4.10%-15.3M

-47.23%-5.74M

-17.98%-4.48M

58.40%-1.54M

-7.18%-3.54M

-10.31%-14.7M

-1.09%-3.9M

-16.86%-3.8M

-148.12%-3.7M

30.14%-3.3M

Net non-operating interest income expense

-1.22%-3.49M

1,066.67%29K

210.53%59K

105.05%177K

-9,989.47%-3.76M

-69,120.00%-3.45M

-106.25%-3K

-40.63%19K

-43,912.50%-3.51M

145.78%38K

Non-operating interest income

-57.51%116K

-46.30%29K

-26.25%59K

-59.70%27K

-98.61%1K

-31.75%273K

-50.91%54K

-32.77%80K

-44.17%67K

41.18%72K

Non-operating interest expense

-3.09%3.61M

-15.02%3.06M

--0

1,511.76%548K

842.78%3.72M

5,709.68%3.6M

-29.89%61K

-75.89%27K

-74.63%34K

Total other finance cost

----

-104.23%-150K

--3.21M

----

--3.55M

----

Other net income (expense)

-169.56%-3.6M

52.79%6.51M

-10.11M

5.17M

906K

4.26M

Gain on sale of security

-146.53%-2.63M

--0

----

38.73%6.51M

---9.14M

--5.65M

--0

--960K

--4.69M

----

Other non- operating income (expenses)

-98.35%-964K

--0

----

---964K

---486K

--0

---54K

---432K

----

Income before tax

-72.49%-22.39M

-46.37%-5.71M

-53.90%-4.42M

275.20%5.15M

-433.61%-17.4M

2.54%-12.98M

-2.44%-3.9M

10.72%-2.87M

-98.38%-2.94M

32.13%-3.26M

Income tax

Net income

-72.49%-22.39M

-46.37%-5.71M

-53.90%-4.42M

275.20%5.15M

-433.61%-17.4M

2.54%-12.98M

-2.44%-3.9M

10.72%-2.87M

-98.38%-2.94M

32.13%-3.26M

Net income continuous Operations

-72.49%-22.39M

-46.37%-5.71M

-53.90%-4.42M

275.20%5.15M

-433.61%-17.4M

2.54%-12.98M

-2.44%-3.9M

10.72%-2.87M

-98.38%-2.94M

32.13%-3.26M

Minority interest income

Net income attributable to the parent company

-72.49%-22.39M

-46.37%-5.71M

-53.90%-4.42M

275.20%5.15M

-433.61%-17.4M

2.54%-12.98M

-2.44%-3.9M

10.72%-2.87M

-98.38%-2.94M

32.13%-3.26M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-72.49%-22.39M

-46.37%-5.71M

-53.90%-4.42M

275.20%5.15M

-433.61%-17.4M

2.54%-12.98M

-2.44%-3.9M

10.72%-2.87M

-98.38%-2.94M

32.13%-3.26M

Basic earnings per share

85.13%-7.25

91.59%-1.0299

89.19%-1

104.44%0.5

-58.67%-29.75

54.01%-48.75

30.00%-12.25

63.00%-9.25

23.73%-11.25

63.77%-18.75

Diluted earnings per share

87.61%-7.25

93.85%-1.0299

89.19%-1

98.59%-0.25

-58.67%-29.75

44.81%-58.5

4.29%-16.75

63.00%-9.25

-20.34%-17.75

63.77%-18.75

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	4.10%15.3M	47.23%5.74M	17.98%4.48M	-58.40%1.54M	7.18%3.54M	10.31%14.7M	1.09%3.9M	16.86%3.8M	148.12%3.7M	-30.14%3.3M
Selling and administrative expenses	22.06%12.13M	33.33%4.17M	43.64%3.44M	-23.65%1.68M	28.29%2.84M	16.33%9.94M	31.51%3.13M	19.97%2.4M	14.50%2.2M	-1.43%2.21M
-General and administrative expense	22.06%12.13M	33.33%4.17M	43.64%3.44M	-23.65%1.68M	28.29%2.84M	16.33%9.94M	31.51%3.13M	19.97%2.4M	14.50%2.2M	-1.43%2.21M
Research and development costs	-20.80%8.38M	34.54%2.94M	-14.77%2.44M	-55.07%1.25M	-36.45%1.76M	9.18%10.58M	-21.76%2.19M	14.64%2.86M	95.28%2.77M	-7.38%2.76M
Other operating expenses	10.49%-5.21M	3.19%-1.37M	4.05%-1.4M	-8.68%-1.39M	36.85%-1.06M	-18.54%-5.82M	-7.54%-1.41M	-17.42%-1.46M	31.01%-1.28M	-231.42%-1.68M
Operating profit	-4.10%-15.3M	-47.23%-5.74M	-17.98%-4.48M	58.40%-1.54M	-7.18%-3.54M	-10.31%-14.7M	-1.09%-3.9M	-16.86%-3.8M	-148.12%-3.7M	30.14%-3.3M
Net non-operating interest income expense	-1.22%-3.49M	1,066.67%29K	210.53%59K	105.05%177K	-9,989.47%-3.76M	-69,120.00%-3.45M	-106.25%-3K	-40.63%19K	-43,912.50%-3.51M	145.78%38K
Non-operating interest income	-57.51%116K	-46.30%29K	-26.25%59K	-59.70%27K	-98.61%1K	-31.75%273K	-50.91%54K	-32.77%80K	-44.17%67K	41.18%72K
Non-operating interest expense	-3.09%3.61M	-15.02%3.06M	--0	--0	1,511.76%548K	842.78%3.72M	5,709.68%3.6M	-29.89%61K	-75.89%27K	-74.63%34K
Total other finance cost	----	----	----	-104.23%-150K	--3.21M	----	----	----	--3.55M	----
Other net income (expense)	-169.56%-3.6M	0		52.79%6.51M	-10.11M	5.17M	0	906K	4.26M
Gain on sale of security	-146.53%-2.63M	--0	----	38.73%6.51M	---9.14M	--5.65M	--0	--960K	--4.69M	----
Other non- operating income (expenses)	-98.35%-964K	--0	----	----	---964K	---486K	--0	---54K	---432K	----
Income before tax	-72.49%-22.39M	-46.37%-5.71M	-53.90%-4.42M	275.20%5.15M	-433.61%-17.4M	2.54%-12.98M	-2.44%-3.9M	10.72%-2.87M	-98.38%-2.94M	32.13%-3.26M
Income tax
Net income	-72.49%-22.39M	-46.37%-5.71M	-53.90%-4.42M	275.20%5.15M	-433.61%-17.4M	2.54%-12.98M	-2.44%-3.9M	10.72%-2.87M	-98.38%-2.94M	32.13%-3.26M
Net income continuous Operations	-72.49%-22.39M	-46.37%-5.71M	-53.90%-4.42M	275.20%5.15M	-433.61%-17.4M	2.54%-12.98M	-2.44%-3.9M	10.72%-2.87M	-98.38%-2.94M	32.13%-3.26M
Minority interest income
Net income attributable to the parent company	-72.49%-22.39M	-46.37%-5.71M	-53.90%-4.42M	275.20%5.15M	-433.61%-17.4M	2.54%-12.98M	-2.44%-3.9M	10.72%-2.87M	-98.38%-2.94M	32.13%-3.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-72.49%-22.39M	-46.37%-5.71M	-53.90%-4.42M	275.20%5.15M	-433.61%-17.4M	2.54%-12.98M	-2.44%-3.9M	10.72%-2.87M	-98.38%-2.94M	32.13%-3.26M
Basic earnings per share	85.13%-7.25	91.59%-1.0299	89.19%-1	104.44%0.5	-58.67%-29.75	54.01%-48.75	30.00%-12.25	63.00%-9.25	23.73%-11.25	63.77%-18.75
Diluted earnings per share	87.61%-7.25	93.85%-1.0299	89.19%-1	98.59%-0.25	-58.67%-29.75	44.81%-58.5	4.29%-16.75	63.00%-9.25	-20.34%-17.75	63.77%-18.75
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm